Since the analysis of clinical specimens revealed an inverse correlation between SOX17 and NRF2, we suggested that the downregulated transcription activity of SOX17 in ESCC may cause dysregulation of cytoprotective enzymes controlled by NRF2, resulting in CCRT resistance. The gene discussed is NFE2L2; the disease is esophageal squamous cell carcinoma.